INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS

Show other versions (1)

<em>The article discusses the problem of basis therapy in patients with chronic Pseudomonas aeruginosa infection and cystic fibrosis. Authors showed the safety, good tolerance and high efficacy of constant treatment with special tobramycin solution delivered by nebulizer (Tobi) in children inc...

Full description

Bibliographic Details
Main Authors:	O.I. Simonova, V.P. Chistyakova, A.V. Lazareva, L.K. Katosova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2011-01-01
Series:	Вопросы современной педиатрии
Online Access:	http://vsp.spr-journal.ru:80/jour/article/view/624

Similar Items

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O.I. Simonova, et al.
Published: (2011-05-01)

SOLUTION OF THE PROBLEM OF PSEUDOMONAS INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2014-01-01)

PECULIARITIES OF AMOXICILLIN AND CLAVULANIC ACID APPLICATION AMONG CHILDREN, SUFFERING FROM CHRONIC OBSTRUCTION LUNG DISEASES
by: O.I. Simonova, et al.
Published: (2007-07-01)

PECULIARITIES OF AMOXICILLIN AND CLAVULANIC ACID APPLICATION AMONG CHILDREN, SUFFERING FROM CHRONIC OBSTRUCTION LUNG DISEASES
by: O.I. Simonova, et al.
Published: (2007-01-01)

Pharmacotherapy of cystic fibrosis: inhaled antibiotics
by: N. I. Kapranov
Published: (2013-12-01)

NEW METHOD OF CONSERVATIVE TREATMENT OF CHRONIC RHINOSINUSITIS IN CHILDREN WITH CYSTIC FIBROSIS
by: S.G. Ushakova, et al.
Published: (2010-01-01)

NEW METHOD OF CONSERVATIVE TREATMENT OF CHRONIC RHINOSINUSITIS IN CHILDREN WITH CYSTIC FIBROSIS
by: S.G. Ushakova, et al.
Published: (2010-09-01)

PECULIARITIES OF REPLACEMENT ENZYME THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: BENEFITS OF HIGH-TECH ENZYMES
by: O.I. Simonova, et al.
Published: (2011-01-01)

PECULIARITIES OF REPLACEMENT ENZYME THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: BENEFITS OF HIGH-TECH ENZYMES
by: O.I. Simonova, et al.
Published: (2011-09-01)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01)

Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center
by: Danish Abdul Aziz, et al.
Published: (2022-01-01)

Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
by: S.I. Ilchenko, et al.
Published: (2022-09-01)

Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Prerequisites for a dry powder inhaler for children with cystic fibrosis.
by: Anne J Lexmond, et al.
Published: (2017-01-01)

Clinical and functional control of mucolytic therapy in children with cystic fibrosis
by: O. I. Simonova, et al.
Published: (2022-04-01)

Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis
by: Meng-Jiao Xu, et al.
Published: (2020-06-01)

THE PERFORMANCE OF A LONG-TERM ANTIBACTERIAL THERAPY IN CHILDREN WITH CYSTIC FIBROSIS DURING PRIMARY PLATING OF PSEUDOMONAS AERUGINOSA
by: О. I. Simonova, et al.
Published: (2014-12-01)

Clinical significance of lung microbiota and efficiency of the inhaled antibacterial therapy of cystic fibrosis in children
by: E. V. Pavlinova, et al.
Published: (2019-03-01)

Imaging of the bacterial interactions in lung co-infection in cystic fibrosis patients
by: Burkaltseva M.V., et al.
Published: (2020-05-01)

Enhancing adherence to inhaled therapies in cystic fibrosis
by: Paula Lomas
Published: (2014-04-01)

Use of inhaled tobramycin in patients with cystic fibrosis
by: A G Chermensky, et al.
Published: (2010-08-01)

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
by: Elizabeth Claire Elson, et al.
Published: (2019-04-01)

NEW POSSIBILITIES OF ANTIBACTERIAL TREATMENT IN ACUTE AND CHRONIC RESPIRATORY DISORDERS IN CHILDREN
by: O. I. Simonova, et al.
Published: (2013-02-01)

Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis
by: K.V. Skriabinа, et al.
Published: (2023-04-01)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
by: Xiaoxuan Han, et al.
Published: (2023-05-01)

Inhaled therapy in cystic fibrosis: agents, devices and regimens
by: Penny Agent, et al.
Published: (2015-06-01)

INHALATION THERAPY: WHAT ITS ACTIVITY DEPENDS ON?
by: O.I. Simonova
Published: (2008-01-01)

INHALATION THERAPY: WHAT ITS ACTIVITY DEPENDS ON?
by: O.I. Simonova
Published: (2008-08-01)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Infections in Cystic Fibrosis
by: Danni Li, et al.
Published: (2023-02-01)

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
by: Martha K Daddario, et al.
Published: (2010-10-01)

Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin
by: Anne M. Akkerman-Nijland, et al.
Published: (2020-02-01)

Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
by: Julie Ann Justo, et al.
Published: (2013-10-01)

Targeted Therapy for Cystic Fibrosis in Children
by: A. V. Burlutskaya, et al.
Published: (2023-11-01)

Significance of fructosamine in the diagnosis of carbohydrate metabolism disorders in children with cystic fibrosis
by: N. V. Liabina, et al.
Published: (2022-03-01)

THE ALGORITHM OF COMPLEX SYNDROME-ORIENTED THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: A MODERN APPROACH
by: Yu. V. Gorinova, et al.
Published: (2013-09-01)

Adherence to inhalation therapy and quality of life in children with cystic fibrosis: a cross-sectional study
by: Thaís Peruch, et al.
Published: (2021-02-01)

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis
by: Kelly Amber, et al.
Published: (2011-09-01)

Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Infection in Cystic Fibrosis
by: John Lam, et al.
Published: (2013-01-01)

Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data
by: Hamed K, et al.
Published: (2017-04-01)